FDA Investigator Susan P Bruederle

Susan P Bruederle has inspections in 9 countries as of 06 Oct 2023. Susan P Bruederle has collaborated with a combinined 7573 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
97
Last Inspection Date:
06 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United Kingdom of Great Britain and Northern Ireland, United States of America, France, Switzerland, Canada, Germany, Ireland, Portugal, Italy
Co-Investigator(s):
Ademola O Daramola, Aditi S Thakur, Alan M Barker, Alan M Roberts, Alicia M Mozzachio, Amanda L Baskin, Amanda S Zorn, Amina Bashir, Amy Devlin, PhD, Anastasia G Lolas, Anastasia M Shields, Anders W Evenson, Andrace Lde Yampert, Andrea D Swingle, Andrew A Leboeuf, Andrew J Barrowcliff, Ann Marie Montemurro, Ann Marie Schofield, Anthony F Lorenzo, Ariel Cruz Figueroa, Arsen Karapetyan, Ashley L Reiber, Ashutosh Rao, PhD, Azza Talaat, Barry Cherney, PhD, Bei Y He, Benjamin J Smith, Bo Chi, PhD, Brandon C Heitmeier, Brandy N Lepage, Brentley S Collins, Brian D Garthwaite, Brian D Nicholas, Brian D Nicholson, Brian D Rogers, Brittani N Franklin, Brittany D Terhar, Brooke K Higgins, Bruce H Mccullough, Bruce M Mccullough, Bryan L Mcguckin, Burnell M Henry, Byungja E Marciante, Carl A Anderson, Carl A Huffman, III, Carlyn L Ray, Carrie Ann Plucinski, Caryn M Mcnab, Catherine V Quinlan, CDR Ileana Barreto Pettit, CDR Sean T Creighton, Chad E Schmear, Chad W Rice, Charisse K Green, Charles I Ann, Charles L Zhou, Cheryl A Kmiec, Christian D Lynch (CDL), Christina A Miller, Christina V Santos, Christine W Twohy, Christopher D Leach, Chryste D Best, Claire M Minden, Constantin Y Philopoulos, Corrine M Carter, Cynthia J Lee, MS, Cynthia Jim, CSO, Danial S Hutchison, Daniel B Arrecis, Daniel J Brown, Dariusz Galezowski, Darrell E Luedtke, Darren S Morgan, David A Paterson, David D Anderson, PhD, David J Gasparovich, David L Duncan, David Perkins, Dawn C Olenjack, Debara R Reese, Debara Reese, Deborah M Trout, Debra I Love, Denarvis C Mendenhall, Denise L Burosh, Denise M Digiulio, Dennis Cantellops Paite, Dennis E Guilfoyle, PhD, Devaughn Edwards, Dina A Tallman, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Donna A Katz, Donna Mwilliams Hill, Dr. Abhijit Raha, PhD, Dr. Andrew Shroke, Dr. Gang Wang, PhD, Dr. Ralph M Bernstein, PhD, Eboni S Funderburk, Edwin Melendez, Eliezar Ramos, Elizabeth L Philpy, Emest F Bizjak, Emily J Orban, Enrico Joset Mangahis, Enrico Mangahis, Eric M Mueller, PharmD, Eric S Pittman, Erika V Butler, Etty Feller, Felix Maldonado, Frances Namuswe, PhD, Frank Wackes, French, Gene D Arcy, Geneve M Maxwell, Geneve M Parks, Geneve Maxwell, Gerald B Seaborn, Jr, Gerard Pde Leon, Goran Periz, PhD, Greg Brinsley, Gregory Price, Gregory R Brinsley, Gregory R Dill, Guerlain Ulysse, Gwyn G Dickinson, Heika R Tait, Helen B Ricalde, Herbert M Corbello, Howard Sklamberg, Hugh M Mcclure, II, Humera Khan, Humera T Khan, Iram R Hassan, PhD, Ivis L Negrón, Ivis Lnegron Torres, Jacob G Luts, Jacob G Lutz, Jacqueline Mdiaz Albertini, James I Giefer, James K Ireland, James L Dunnie, Jr, James W Plucinski, Janae D Price, Janet L Bowen, Janis R Armedoriz, Jason F Chancey, Jean Blackston Hill, Jean Blackstone Hill, Jeanne J Chiu, Jeanne M Morris, Jeffrey A Sommers, Jeffrey D Meng, Jeffrey P Raimondi, Jennifer A Kemp, Jennifer C Adams, Jennifer C Johnson, Jennifer D Hollstrom, Jennifer L Huntington, Jennifer L Schmidt, Jennifer M Gogley, Jeremy W Rotton, Jesse A Vazquez, Joanne E King, Joanne Heim, Joey V Quitania, John M Seale, John Misock, Jonathan G Swoboda, Jorge F Christian, Jorge L Guadalupe, Joris Vanloco, Jose Acruz Gonzalez, Jose E Melendez, DDC, Jose M Cayuela, Jose R Lopez, Joseph A Morkunas, Joseph A Piechocki, Joseph R Strelnik, Joshua M Adams, Juhong Liu, PhD, Junho Pak, Justin A Boyd, Karen E Masley, Karen Emasley Joseph, Karen M Montgomery (KMM), Katherine Szestypalow, Kathryn E Ogger, Kathy E Craven, Kathy E Noe, Kellia N Hicks, Kevin A Gonzalez, Kevin D Kallander, Kevin P Regan, Kim Lthomas Cruse, Kshitij A Patkar, Kyran R Gibson, L'oreal F Walker, Lance M De Souza, MBA, Larry K Austin, Latoya A Griffith, Laura Fontan, MS, Laurel A Beer, Lauren Iacono Connors, PhD, Laurie A Haxel, Laurimer Kuilan Torres, LCDR Debra Emerson, LCDR Mark A Jimenez, RN, LCDR Randall L Morris, Leigh Anne Myers, Lequita M Mayhew, Leslie A Paul, Lewis K Antwi, Libia M Lugo, Linda F Murphy, Lindsey S Fleischman, Lisa C Lewis, Lisa Hayka, Lisa Hornback, Lisa M Bellows, Lisa M Feola, Lorelei S Jarrell, Lorie S Hannappel, Luella J Rossi, Lynda L Lanning, M Aabel I, Madushini Dharmasena, PhD, Maksim A Levenchuk, Margaret M Annes, Margaret Torres Vazquez, Maria Joselopez Barragan, PhD, Marianela Aponte Cruz, Marion Michaelis, Marisa E Stock, Mark E Frank, Mark G Peterson, Martha Sullivan Myrick, Martin R Vowell, Mary E Storch, Matthew J Gretkierewicz, Meisha R Sampson, Meisha Waters, Melanie M Walker, Melina Rodriguez Upton, Melissa J Garcia, Mercy Oyugi, Meredith P Soehl, Investigator, Michael A Charles, Michael D Robinson, Michael E Maselli, Michael Shanks, MS, Michael Y Philopoulos, Michele L Forster, PhD, Michele L Glendenning, Michele L Obert, Michele Perry Williams, Mihaly S Ligmond, Milva E Melendez, Milva Emelendez Perales, Mindy M Chou, Minh D Phan, Mizanne E Lewis, Montgomery Montgomery, Karen M, Mra Davism, Mra Mcculloughj, Mra Narulaa, Muna Algharibeh, Muralidhara B Gavini, PhD, Myra K Casey, Nadeem I Chaudhry, Nailing Zhang, Nayan J Patel, Neali H Lucas, Nebil A Oumer, Nibin Varghese, MS, Nicholas F Lyons, Nicholas J Presto, Nicholas P Diorio, Nicholas Z Lu, Nicole J Clausen, Noreen Muniz, Norman K Starks, Norman Wong, Omotunde O Osunsanmi, Paola S Barnett, Parul M Patel, Patrica A Cochran, Patricia A Cochran, Patricia A Mcilroy, Patricia H Dlugosz, Patrick B Cummings, Patrick C Klotzbuecher, Patsy I Domingo, Patsy J Domingo, Paul A Bonneau, Paula A Trost, Peng "Jeff" Zhou, Peng Zhou, Philip A Klimkewicz, Philip F Istafanos, DMV, MS, Phung Thien Nguyen, Prabhu P Raju, Qiao Y Bobo, Rachel T Evans, Rafael Nevarez Nieves, Rafael Padilla, Rafeeq A Habeeb, Ralph A Erickson, Ralph H Vocque, Ramon E Martinez, Raymond R Roy, PhD, Raymond T Oji, Rebecca E Dombrowski, Rebecca K Olin, Rebecca Rodriguez, Regina T Brown, Renee S Blosser, Reyes Candau Chacon, PhD, Richard H Penta, Richard Heath Coats, Richard J Friedman, Richard L Friedman, Richard T Riggie, Richmond K Yip, Robert C Coleman, Robert D Tollefsen, Robert J Ham, Robert J Martin, Robert M Barbosa, Robert M Tillman, Robert R Barbosa, Robert Rodriguez, Roberta W Cunningham, Roger F Zabinski, Rona Leblanc, PhD, Ronald G Crawford, Rose M Ashley, Rose Xu, Ross J Grigsby, Russ R Rivy, Russell K Riley, Ruth Moore, PhD, S Lori Brown, PhD MPH, Samina S Khan, Samuel W Labinjo, Sandra A Boyd, Sandra A Hughes, Sangeeta M Khurana, PhD, Sanket N Patel, Santos E Camara, Sarah E Rhoades, Sarah M Napier, Satheesh Thomas, Schwierjohann Schwierjohann, Lindsey, Scott A Golladay, Scott T Ballard, Sean R Bryd, Shafiq S Ahadi, Shana L Williams, Sharon K Thoma, PharmD, Shirley J Berryman, Sidney B Priesmeyer, Simone E Pitts, Sixto M Mercado Rios, State Agency, Stefen D Mcmillan, Stephen C Mahoney, Stephen D Brown, Stephen D Eich, Steven C Madzo, Steven M Weinman, Steven P Donald, Sudha Shukla, Susan D Yuscius, Susan F Laska, MS, Susan M Jackson, Susan W Ciani, Susanna E Ford, Analyst, Suyang Qin, Tamara Brey, Tara R Gooen, That Q Dang, Thomas A Peter, Thomas E Friel, Thomas J Arista, Thomas J Cosgrove, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Timothy C Schell, Tina M Pawlowski, Todd M Stankewicz, Tonnie L Carter, Torrance J Slayton, Tracey Asinjen Wiersma, Unnee Ranjan, Vaishali J Patel, Vioela J Caze, Walden H Lee, Wayne E Seifert, Wendy G Tan, PhD, William D Sherman, William D Tingley, William Hallett, PhD, Xiaokuang Lai, PhD, Xiaoping Guan, Xiomara Copeland, Yangmin Ning, Yasamin Ameri, Ying Xin Fan, PhD, Yonggang Wang, PhD, Yumi J Hiramine, Yvonne E Lozano, Yvonne Lozano, Zhihao Qiu (Peter), PhD, Zhong Li, PhD

Susan P Bruederle's Documents

Publish Date Document Type Title
November, 2002 FDA 483 Hydrox Laboratories - Form 483, 2002-11-26
August, 2002 EIR Laborchemie Apolda GmbH - EIR, 2002-08-28
July, 2002 EIR Nanophase Technologies Corporation - EIR, 2002-07-25
September, 2003 FDA 483 Response Recipharm HC Limited - Form 483R, 2003-09-23
November, 2000 FDA 483 Aventis Pharma, Ltd. - Form 483, 2000-11-17
April, 2001 EIR AbbVie Inc. - EIR, 2001-04-30
September, 2000 EIR Rising Pharma Holdings, Inc. - EIR, 2000-09-15
January, 2006 FDA 483 Norbrook Laboratories Limited - Form 483, 2006-01-26
August, 2003 FDA 483 Degussa Limited - Form 483, 2003-08-29
February, 2008 EIR ANDERSONBRECON INC. - EIR, 2008-02-05
September, 2003 FDA 483 Response SF-Chem - Form 483R, 2003-10-23
November, 2001 EIR Sanofi Winthrop Industrie - EIR, 2001-11-27
March, 2002 FDA 483 Response Morton Grove Pharmaceuticals, Inc. - Form 483R, 2002-09-03
November, 2001 FDA 483 Aventis Pharma Specialties - Form 483, 2001-11-27
May, 2000 FDA 483 Morton Grove Pharmaceuticals, Inc. - Form 483, 2000-05-04
September, 2001 FDA 483 Baxter Healthcare Corporation - Form 483, 2001-08-17
March, 2001 FDA 483 Response Morton Grove Pharmaceuticals, Inc. - Form 483R, 2001-03-23
March, 2002 FDA 483 Morton Grove Pharmaceuticals, Inc. - Form 483, 2002-03-08
September, 2003 EIR SF-Chem - EIR, 2003-09-09
May, 2005 FDA 483 Eli Lilly and Company - Form 483, 2005-05-19
May, 2002 FDA 483 Eli Lilly and Company - Form 483, 2002-05-30
November, 2006 FDA 483 FIRST PRIORITY INCORPORATED - Form 483, 2006-11-09
January, 2000 FDA 483 Response Fresenius Kabi USA, LLC - Form 483R, 2000-08-22
May, 2003 EIR Eli Lilly and Company - EIR, 2003-05-29
June, 2002 FDA 483 Response Labcorp Drug Development Inc. - Form 483R, 2002-06-14
June, 2007 FDA 483 HIKMA FARMACEUTICA (PORTUGAL), S.A - Form 483, 2007-06-08
August, 2003 FDA 483 Response Degussa Limited - Form 483R, 2003-12-01
January, 2000 EIR Fresenius Kabi USA, LLC - EIR, 2000-01-11
November, 2006 EIR FIRST PRIORITY INCORPORATED - EIR, 2006-11-09
August, 2003 EIR Degussa Limited - EIR, 2003-11-12
November, 2001 FDA 483 Response Sanofi Winthrop Industrie - Form 483R, 2001-12-17
January, 2000 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2000-01-11
May, 2003 FDA 483 Eli Lilly and Company - Form 483, 2003-05-29
July, 2002 EIR Nanophase Technologies Corporation - EIR, 2002-07-29
September, 2001 EIR Baxter Healthcare Corporation - EIR, 2001-08-17
May, 2000 EIR Morton Grove Pharmaceuticals, Inc. - EIR, 2000-05-04
November, 2000 EIR Pfizer Ireland Pharmaceuticals - EIR, 2000-11-03
May, 2005 FDA 483 Response Eli Lilly and Company - Form 483R, 2005-05-19
September, 2001 EIR Baxter Healthcare Corporation - EIR, 2001-09-07
September, 2000 FDA 483 Rising Pharma Holdings, Inc. - Form 483, 2000-09-15
May, 2004 FDA 483 Bigmar-Bioren Pharmaceuticals SA - Form 483, 2004-05-13
January, 2008 FDA 483 Bodycote Testing Group - Polymers - Form 483, 2008-01-29
March, 2005 FDA 483 Response ACS Dobfar SPA - Form 483R, 2005-04-04
November, 2006 FDA 483 Response FIRST PRIORITY INCORPORATED - Form 483R, 2007-02-16
March, 2005 FDA 483 ACS Dobfar SPA - Form 483, 2005-03-24
September, 2001 FDA 483 Response Baxter Healthcare Corporation - Form 483R, 2001-08-28
April, 2008 FDA 483 Ferring GmbH - Form 483, 2008-04-25
March, 2002 EIR Morton Grove Pharmaceuticals, Inc. - EIR, 2002-03-08
August, 2003 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2003-08-14
September, 2003 FDA 483 Aventis Pharma, Ltd. - Form 483, 2003-09-05
March, 2008 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2008-03-18
January, 2006 FDA 483 Norbrook Laboratories Limited - Form 483, 2006-01-26
May, 2000 FDA 483 Response Morton Grove Pharmaceuticals, Inc. - Form 483R, 2000-05-22
June, 2002 EIR Labcorp Drug Development Inc. - EIR, 2002-03-22
June, 2006 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2006-06-29
June, 2002 FDA 483 Labcorp Drug Development Inc. - Form 483, 2002-06-04
September, 2005 EIR Rising Pharma Holdings, Inc. - EIR, 2005-09-08
May, 2002 FDA 483 Response Eli Lilly and Company - Form 483R, 2002-05-30
August, 2003 EIR Fresenius Kabi USA, LLC - EIR, 2003-08-14
June, 2002 FDA 483 Response Labcorp Drug Development Inc. - Form 483R, 2002-06-14
December, 2002 EIR Woodstock Sterile Solutions, Inc - EIR, 2002-12-18
May, 2002 EIR Eli Lilly and Company - EIR, 2002-05-30
September, 2003 EIR Recipharm HC Limited - EIR, 2003-12-17
May, 2008 FDA 483 Hydrox Laboratories - Form 483, 2008-05-09
April, 2001 FDA 483 Response AbbVie Inc. - Form 483R, 2001-05-18
March, 2001 FDA 483 Morton Grove Pharmaceuticals, Inc. - Form 483, 2001-03-01
March, 2005 EIR ACS Dobfar SPA - EIR, 2005-03-24
April, 2001 FDA 483 AbbVie Inc. - Form 483, 2001-04-30
March, 2001 EIR Morton Grove Pharmaceuticals, Inc. - EIR, 2001-03-01
June, 2002 FDA 483 Labcorp Drug Development Inc. - Form 483, 2002-03-22
May, 2002 FDA 483 Eli Lilly & Company - Form 483, 2002-05-30
May, 2005 EIR Eli Lilly and Company - EIR, 2005-05-19
June, 2002 EIR Labcorp Drug Development Inc. - EIR, 2002-05-30

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more